Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35383 |
Cysteamine bitartrate
Mercaptamine bitartrate |
Others | Others |
Cysteamine bitartrate (Mercaptamine bitartrate)是FDA 批准的胱氨酸消耗氨基硫醇药物(cystine-depleting aminothiol agent),通过参与二硫交换减少溶酶体胱氨酸的积累,用于治疗肾病性胱氨酸病。此外,Cysteamine bitartrate 还具有抗氧化特性。 |